The Effects of Limb Elevation During Gout Flare Episodes

Status Not yet recruiting

Clinical Trial Summary

The goal of this open-label randomized controlled trial is to explore the benefit of limb elevation in inpatient gout flare episodes, compared with standard treatment The main questions are; - Is limb elevation able to reduce pain during gout flare episodes to a greater degree compared with standard treatment ? - Is Is limb elevation able to reduce joint swelling during gout flare episodes to a greater degree compared with standard treatment ? Participants will be divided into 2 group; 1. Limb elevation group 2. control group All participants will receive standard medical therapy consisting of colchicine 0.6 mg per day plus prednisolone 30 mg per day for 2 days Pain score and joint circumference will be recored at recruitment, 24 hour and 48 hour

Clinical Trial Description

Limb elevation has shown benefit in ankle sprain and venous insufficiency, but its benefit has not been studied in people with gout flare. In this open-label randomized controlled trial, 30 adults diagnosed with gout flare during their hospitalization will be randomized to receive limb elevation plus standard medication for gout flare (limb elevation group) or standard medication only (control group). Primary outcome is reduction in 10-point visual analogue scale for pain at 48 hours after enrollment and the secondary outcome is the reduction of the circumference of affected joint at 48 hours after enrollment. Comparison of pain score and joint circumference reduction will be made using Wilcoxon Rank-sum test. Our study results may provide some evidence in support of limb elevation as a supplementary non-pharmacological therapy for relief of gout flare. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06207045
Study type	Interventional
Source	Thammasat University
Contact	RatchayaSaitip Lertnawapan
Phone	0973941619
Email	ratchas@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	February 1, 2024
Completion date	October 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05522504` - Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Terminated	`NCT03933007` - Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare	Phase 4
Not yet recruiting	`NCT04069325` - Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy	N/A
Recruiting	`NCT05586958` - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients	Phase 3
Active, not recruiting	`NCT06197828` - Novel Biomarkers for Early Renal Injury in Children With Sepsis
Recruiting	`NCT05586971` - Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients	Phase 3
Not yet recruiting	`NCT04849312` - Prediction of 30-Day Readmission Using Machine Learning
Active, not recruiting	`NCT04784351` - Prediction of Expected Length of Hospital Stay Using Machine Learning
Active, not recruiting	`NCT05045742` - Prediction of Patient Deterioration Using Machine Learning
Completed	`NCT03203759` - Hospital-Level Care at Home for Acutely Ill Adults	N/A
Recruiting	`NCT05936268` - Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare	Phase 2
Active, not recruiting	`NCT03621215` - The Effect of Tart Cherry Juice on Risk of Gout Attacks	N/A
Recruiting	`NCT05658575` - Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/Phase 3
Recruiting	`NCT03524222` - Home Hospital for Suddenly Ill Adults	N/A
Not yet recruiting	`NCT06273813` - Treatment of Topical Ketorolac Gel in Acute Gouty Flare	Phase 1
Completed	`NCT04531280` - Rural Home Hospital: Proof of Concept	N/A
Completed	`NCT05256303` - Rural Hospital-Level Care at Home for Acutely Ill Adults	N/A
Completed	`NCT04080570` - Remote Physician Care for Home Hospital Patients	N/A